Menu
Search for
Home
News
Entertainment
Business
Sports
Games
Technology
Health
permission
Health
Admin
November 14, 2024
0
9
Europe is changing its assessment and giving limited approval to lecanemab, a controversial Alzheimer’s disease drug.
Business
Admin
June 4, 2024
0
140
BBVA seeks permission to launch takeover bid for Sabadell
Back to top button
Close
Search for